INTEGRATED BIOPHARMA INC Quarterly Interest Expense in USD from Q4 2010 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
Integrated Biopharma Inc quarterly/annual Interest Expense history and growth rate from Q4 2010 to Q1 2024.
  • Integrated Biopharma Inc Interest Expense for the quarter ending March 31, 2024 was $4K.
  • Integrated Biopharma Inc Interest Expense for the twelve months ending March 31, 2024 was $30K, a 25% decline year-over-year.
  • Integrated Biopharma Inc annual Interest Expense for 2023 was $52K, a 59.4% decline from 2022.
  • Integrated Biopharma Inc annual Interest Expense for 2022 was $128K, a 50% decline from 2021.
  • Integrated Biopharma Inc annual Interest Expense for 2021 was $256K, a 35.5% decline from 2020.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Quarterly (USD)
Interest Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $30K $4K +$6K Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-10
Q4 2023 $24K -$2K -$10K -125% Oct 1, 2023 Dec 31, 2023 10-Q 2024-02-12
Q3 2023 $34K -$8K -$18K -180% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-09
Q2 2023 $52K $36K +$12K +50% Apr 1, 2023 Jun 30, 2023 10-K 2023-09-15
Q1 2023 $40K -$2K -$32K -107% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-10
Q4 2022 $72K $8K -$34K -81% Oct 1, 2022 Dec 31, 2022 10-Q 2024-02-12
Q3 2022 $106K $10K -$22K -68.8% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 $128K $24K -$19K -44.2% Apr 1, 2022 Jun 30, 2022 10-K 2023-09-15
Q1 2022 $147K $30K -$28K -48.3% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q4 2021 $175K $42K -$37K -46.8% Oct 1, 2021 Dec 31, 2021 10-Q 2023-02-10
Q3 2021 $212K $32K -$44K -57.9% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 $256K $43K -$25K -36.8% Apr 1, 2021 Jun 30, 2021 10-K 2022-09-13
Q1 2021 $281K $58K -$38K -39.6% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q4 2020 $319K $79K -$30K -27.5% Oct 1, 2020 Dec 31, 2020 10-Q 2022-02-10
Q3 2020 $349K $76K -$48K -38.7% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-10
Q2 2020 $397K $68K +$24K +54.5% Apr 1, 2020 Jun 30, 2020 10-K 2021-09-02
Q1 2020 $373K $96K -$100K -51% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-13
Q4 2019 $473K $109K -$81K -42.6% Oct 1, 2019 Dec 31, 2019 10-Q 2021-02-12
Q3 2019 $554K $124K -$76K -38% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-12
Q2 2019 $630K $44K -$188K -81% Apr 1, 2019 Jun 30, 2019 10-K 2020-09-23
Q1 2019 $818K $196K -$36K -15.5% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-13
Q4 2018 $854K $190K -$39K -17% Oct 1, 2018 Dec 31, 2018 10-Q 2020-02-12
Q3 2018 $893K $200K -$33K -14.2% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-13
Q2 2018 $926K $232K Apr 1, 2018 Jun 30, 2018 10-K 2019-08-29
Q1 2018 $232K +$7K +3.11% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-15
Q4 2017 $229K +$2K +0.88% Oct 1, 2017 Dec 31, 2017 10-Q 2019-02-13
Q3 2017 $233K +$1K +0.43% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-09
Q1 2017 $225K -$23K -9.27% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-09
Q4 2016 $227K -$16K -6.58% Oct 1, 2016 Dec 31, 2016 10-Q 2018-02-09
Q3 2016 $232K -$5K -2.11% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-09
Q1 2016 $966K $248K -$3K -1.2% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-10
Q4 2015 $969K $243K -$7K -2.8% Oct 1, 2015 Dec 31, 2015 10-Q 2017-02-10
Q3 2015 $976K $237K -$3K -1.25% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-10
Q2 2015 $979K $238K +$5K +2.15% Apr 1, 2015 Jun 30, 2015 10-K 2016-09-02
Q1 2015 $974K $251K +$14K +5.91% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-13
Q4 2014 $960K $250K +$4K +1.63% Oct 1, 2014 Dec 31, 2014 10-Q 2016-02-19
Q3 2014 $956K $240K -$8K -3.23% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-05
Q2 2014 $964K $233K -$11K -4.51% Apr 1, 2014 Jun 30, 2014 10-K 2015-09-04
Q1 2014 $975K $237K -$11K -4.44% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-14
Q4 2013 $986K $246K +$7K +2.93% Oct 1, 2013 Dec 31, 2013 10-Q 2015-02-17
Q3 2013 $979K $248K $0 0% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-07
Q2 2013 $979K $244K -$33K -11.9% Apr 1, 2013 Jun 30, 2013 10-K 2014-09-08
Q1 2013 $1.01M $248K -$38K -13.3% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-14
Q4 2012 $1.05M $239K -$47K -16.4% Oct 1, 2012 Dec 31, 2012 10-Q/A 2014-02-13
Q3 2012 $1.1M $248K -$12K -4.62% Jul 1, 2012 Sep 30, 2012 10-Q 2012-11-19
Q2 2012 $1.11M $277K Apr 1, 2012 Jun 30, 2012 10-K 2013-09-30
Q1 2012 $286K -$187K -39.5% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-15
Q4 2011 $286K -$229K -44.5% Oct 1, 2011 Dec 31, 2011 10-Q 2013-02-19
Q3 2011 $260K Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-19
Q1 2011 $473K Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-21
Q4 2010 $515K Oct 1, 2010 Dec 31, 2010 10-Q 2012-02-21
* An asterisk sign (*) next to the value indicates that the value is likely invalid.